A study using a mouse model of mammary cancer shows that loss of a specific ‘dependence’ receptor, which controls cell survival and death (apoptosis), promotes metastasis formation.
These findings are published in Nature this week and support the tumour-suppressing role of this receptor.
The deleted in colorectal cancer (DCC) gene encodes a dependence receptor and, as its name suggests, is frequently deleted in colorectal cancers and many other cancers.
Anton Berns and colleagues constrain its function as a tumour suppressor gene in a mouse model of mammary carcinoma with mutant DCC.
They demonstrate that loss of DCC leads to a loss of pro-apoptotic activity and enhanced tumour cell survival.
These data indicate that loss of DCC function is not selected for in primary tumour development but that its loss facilitates metastasis.
DCC-deficient metastases have been associated with a worse prognosis and a higher risk of recurrent disease in some cancers.
Source: Nature
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.